CClinicalTrials.gg
CompletedNCT05097612Updated Nov 29, 2023

Evaluation of a Soft Exoskeleton to Support Forward Leaning and Lifting

An interventional study of Placebo LiftSuit Exoskeleton and LiftSuit Exoskeleton (low support level) in Occupational Exposure, sponsored by Swiss Federal Institute of Technology. Completed at 1 site in Switzerland. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-29.

Sponsored by Swiss Federal Institute of Technology · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

In this study the LiftSuit version 2.0 designed by Auxivo AG will be used. The LiftSuit is a soft wearable device that is designed to support workers perform physically demanding tasks including repetitive lifting and working in forward leaning positions. It is put on like a backpack and attached to the body using fabric bands and cuffs. Besides soft fabric parts the LiftSuit contains elastics elements. The elastic elements can be flexibly exchanged by the experimenter. For this experiment elastic elements of known stiffness will be hooked into the fabric frame.

Read the detailed description

In a first step participants will try on the LiftSuit exoskeleton and adjust it to their body under supervision of the experimenter. When the LiftSuit exoskeleton is adjusted to the participant it is taken off to allow placement of sensors. The sensors used to record heart rate (Polar H9 heart rate monitor, Polar Electro Europe AG, Germany), muscle activity from 8 muscles in the back and hip region (Delsys Trigno, Delsys Europe, United Kingdom) and movement kinematics (OptiTrack motion capture system, NaturalPoint Inc., USA) will be placed by the experimenter (or participant him/herself). To verify that the electromyography sensors, are working and to obtain normalization values, participants will be instructed to conduct maximal voluntary contractions of each muscle that are being recorded. If needed single sensors can be replaced. After this the exoskeleton will be put back on.

02

Conditions studied

  • Occupational Exposure
03

In context

Lead sponsor

Swiss Federal Institute of Technology is the lead sponsor of 152 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Included will be volunteers of both sexes within working age (18 to 65 years).

Exclusion criteria

Exclusion Criteria:

  • Participants will be excluded if they cannot perform the tasks (squat lifting and forward leaning) due to physical limitations. Furthermore, people who report acute joint or muscle pain or stiffness, or a self-reported history of such problems will be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Healthy participant

    This is a repeated measures design. All participants receive both the intervention and the placebo comparator.

    Device: Placebo LiftSuit Exoskeleton · Device: LiftSuit Exoskeleton (low support level) · Device: LiftSuit Exoskeleton (medium support level) · Device: LiftSuit Exoskeleton (high support level)

Interventions

  • DevicePlacebo LiftSuit Exoskeleton

    The LiftSuit is a soft passive wearable device that is designed to support the hip and back muscles during forward leaning and lifting. It exerts it function through Elastic Energy Storages (EES). In this condition the EES are removed from the device to create a placebo device.

  • DeviceLiftSuit Exoskeleton (low support level)

    The LiftSuit is a soft passive wearable device that is designed to support the hip and back muscles during forward leaning and lifting. It exerts it function through Elastic Energy Storages (EES). EES of different three different levels of stiffness (low, medium, high stiffness) will be used.

  • DeviceLiftSuit Exoskeleton (medium support level)

    The LiftSuit is a soft passive wearable device that is designed to support the hip and back muscles during forward leaning and lifting. It exerts it function through Elastic Energy Storages (EES). EES of different three different levels of stiffness (low, medium, high stiffness) will be used.

  • DeviceLiftSuit Exoskeleton (high support level)

    The LiftSuit is a soft passive wearable device that is designed to support the hip and back muscles during forward leaning and lifting. It exerts it function through Elastic Energy Storages (EES). EES of different three different levels of stiffness (low, medium, high stiffness) will be used.

06

What researchers measure

Primary outcomes

  1. Change in muscle activity of hip extensor muscles (placebo comparator - low support experimental intervention)

    An elastic band placed external to the body parallel to the spine and over the hip joint is likely to support the muscles that extend the hip and back. Less hip extensor muscle (m. gluteus maximus, hamstrings) activity is expected in LiftSuit conditions compared to the placebo comparator condition.

    Time frame: 2 hours

  2. Change in muscle activity of back extensor muscles (placebo comparator - low support experimental intervention)

    An elastic band placed external to the body paralell to the spine and over the hip joint is likely to support the muscles that extend the hip and back. Less back muscle activity (erector spinae at lumbar and thoracic level) is expected in LiftSuit conditions compared to the placebo comparator condition.

    Time frame: 2 hours

Secondary outcomes

  1. Change in muscle activity of hip extensor muscles related to stiffness level of the Elastic Energy Storages (low, medium, high stiffness).

    A reduction in muscle activity is expected. This reduction is expected to be related to the stiffness level of the EES. With high stiffness, leading to more support, leading to less muscle activity.

    Time frame: 2 hours

  2. Change in muscle activity of back muscles related to stiffness level of the Elastic Energy Storages (low, medium, high stiffness).

    The reduction in muscle activity is expected to be related to the stiffness level of the EES. With high stiffness, leading to more support, leading to less muscle activity.

    Time frame: 2 hours

Other outcomes

  1. Change in muscle activity of abdominal muscles (placebo comparator - experimental intervention)

    An elastic band placed external to the body over the hip joint is likely to support the muscles that extend the hip. It could be that this setup might heightened levels of activity in the abdomen.

    Time frame: 2 hours

  2. Change in hip angle kinematics (placebo comparator - experimental intervention)

    Changed forces around the hip joint might influence movement kinematics of this joint. Changes in position and acceleration of the joint angle will be calculated.

    Time frame: 2 hours

07

Study locations

1 site
  • ETH Zurich, Rehabilitation Engeineering Laboratory
    Zurich, 8008, Switzerland
08

References and documents

Individual participant data

Plan to share: No — Device to be ready for the market

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05097612
Lead sponsor
Swiss Federal Institute of Technology
Collaborators
Auxivo AG
Responsible party
Sponsor
First posted
Oct 28, 2021
Start date
Nov 8, 2021
Primary completion
Jan 31, 2022
Completion
Jan 31, 2022
Last update
Nov 29, 2023

Study contacts

Olivier Lambercy, PhD
principal investigator · Swiss Federal Institute of Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion